Questions, questions. For the last few decades, medical study databases have been growing, and so more data is available for study. As a...

BAP1 testing is a relatively straightforward process for trained persons using good equipment. Indeed, that’s true for most tests seeking...

Some say that change is the predominant theme in asbestos litigation. For 2014, some of the change arrives in the form of at least five...

Through the procedures of CMS under the statute governing regarding Medicare, there is news that Medicare is highly likely to start...

A key quote from AACR’s 2014 Cancer Progress Report: “During a telephone news briefing, the association’s leadership said that with an...

Investing in more mesothelioma research should be a no brainer. Investments in research should be flowing from many, including especially...

iMig has posted videos of plenary sessions from Day 1 iMig 2014, and summaries of some other sessions. Best of Imig 2014 – Day 1 is...

Day 2 of iMig 2014 is on October 22,  and is not your father’s mesothelioma science conference. In the past, there was little positive to...

Need more proof that the future of toxic torts will involve molecular issues? Consider that the impact of gene sequencing shows up in...

Happy Friday, with really good news for kids with a form of leukemia. A new press release and an October 16, 2014 article in Fierce...

Some see lung cancer claiming as associated only with the Napoli Bern law firm. But that’s not correct.  More and more, members of the...

Courts hearing toxic tort cases are continuing to open the doors to genomic and other molecular analysis. Proof? A new order in a...

Today is “mesothelioma awareness day.” Obviously most mass tort lawyers know something about mesothelioma. The rest of the world,...

Every seven seconds, someone in the US dies because of a blood cancer, such as a lymphoma or a leukemia. In their honor, and to raise...

Changes in the world of science mean that tort lawyers of today and tomorrow soon will see and learn far more about genomic mutations in...

Nature Genetics includes a free, very useful article on copy number variations across cancers of all types. The review is based on a...

The story of asbestos disease – and the resulting litigation – is part of the larger story of “occupational cancer.”  A new op-ed (free...

It may be the corporate boards are starting to get the message about the need to pay attention to science, technology and cybersecurity....

Most insurers, defendants and various interested others can and should be spending money to find additional causes of mesothelioma. The...

It’s a necessary but sobering annual rite of spring – ASCO members arrive in Chicago for the annual meeting of oncologists at McCormick...